United States · FDA National Drug Code directory

PRAVASTATIN SODIUM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69097-788_9e7d6fa3-832b-40ab-9762-0e242c9c84a6
Product NDC: 69097-788
Form: TABLET
Composition / generic term: PRAVASTATIN SODIUM
Labeler: CIPLA USA INC.
Marketing category: ANDA
Marketing start / end (source format): 20240601
Source listing expiry: 20271231

Source-listed ingredients

PRAVASTATIN SODIUM — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET in 1 BOTTLE (69097-788-05) · 69097-788-05
500 TABLET in 1 BOTTLE (69097-788-12) · 69097-788-12

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →